163 related articles for article (PubMed ID: 28132064)
21. Human pegivirus molecular epidemiology in Argentina: potential contribution of Latin American migration to genotype 3 circulation.
Trinks J; Maestri M; Oliveto F; Del Pino N; Weissenbacher M; Torres OW; Oubiña JR
J Med Virol; 2014 Dec; 86(12):2076-83. PubMed ID: 24615742
[TBL] [Abstract][Full Text] [Related]
22. A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection.
Wang H; Wan Z; Xu R; Guan Y; Zhu N; Li J; Xie Z; Lu A; Zhang F; Fu Y; Tang S
Clin Infect Dis; 2018 Jan; 66(1):29-35. PubMed ID: 29020289
[TBL] [Abstract][Full Text] [Related]
23. Interplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from Prevalence and Genotype Analysis.
Köksal MO; Pirkl M; Sarsar K; Ilktaç M; Horemheb-Rubio G; Yaman M; Meşe S; Eraksoy H; Akgül B; Ağaçfidan A
Viruses; 2023 Dec; 16(1):. PubMed ID: 38275941
[TBL] [Abstract][Full Text] [Related]
24. Phylogenetic Analysis and Epidemic History of Hepatitis C Virus Genotype 2 in Tunisia, North Africa.
Rajhi M; Ghedira K; Chouikha A; Djebbi A; Cheikh I; Ben Yahia A; Sadraoui A; Hammami W; Azouz M; Ben Mami N; Triki H
PLoS One; 2016; 11(4):e0153761. PubMed ID: 27100294
[TBL] [Abstract][Full Text] [Related]
25. Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
N'Guessan KF; Boyce C; Kwara A; Archampong TNA; Lartey M; Sagoe KW; Kenu E; Obo-Akwa A; Blackard JT
Virus Genes; 2018 Jun; 54(3):361-367. PubMed ID: 29551002
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved Infections.
Coller KE; Berg MG; Frankel M; Forberg K; Surani R; Chiu CY; Hackett J; Dawson GJ
J Clin Microbiol; 2016 Aug; 54(8):2023-30. PubMed ID: 27225404
[TBL] [Abstract][Full Text] [Related]
27. Second Human Pegivirus in Hepatitis C Virus-Infected and Hepatitis C Virus/HIV-1-Co-infected Persons Who Inject Drugs, China.
Wang H; Wan Z; Sun Q; Zhu N; Li T; Ren X; An X; Deng S; Wu Y; Li X; Li L; Li J; Tong Y; Tang S
Emerg Infect Dis; 2018 May; 24(5):908-911. PubMed ID: 29664364
[TBL] [Abstract][Full Text] [Related]
28. HCV genotype determination in monoinfected and HIV co-infected patients in Cuba.
Rodríguez Lay Lde L; Villalba MC; Corredor MB; Frómeta SS; Hernández JM; Carrera SD; Wong MS; Samada M; Núñez MB; Alonso LV; da Silva Filho HP; Hübschen JM; Reis MG
Trans R Soc Trop Med Hyg; 2012 Dec; 106(12):711-7. PubMed ID: 23078671
[TBL] [Abstract][Full Text] [Related]
29. High prevalence and viremia of human pegivirus 2 in the HIV-infected population in Honghe Prefecture, Yunnan Province.
Li T; Tang S; Su Y; Bao Z; Wang X; Liu Y; Li H; Han J; Pei Z; Wan Z; Fan H; Tong Y; Li L; Wang N; Li J
Arch Virol; 2020 Mar; 165(3):619-626. PubMed ID: 31965315
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C and Human Pegivirus Coinfection in Patients with Chronic Hepatitis C from the Brazilian Amazon Region: Prevalence, Genotypes and Clinical Data.
Nunes PF; da Cruz Coelho E; da Silva JR; da Silva Costa CC; Sampaio RMA; Frade PCR; Ponteira NA; da Cruz SS; Seabra AD; Carneiro DM; Burbano RMR; Martins LC
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766298
[TBL] [Abstract][Full Text] [Related]
31. Deep sequencing identifies two genotypes and high viral genetic diversity of human pegivirus (GB virus C) in rural Ugandan patients.
Ghai RR; Sibley SD; Lauck M; Dinis JM; Bailey AL; Chapman CA; Omeja P; Friedrich TC; O'Connor DH; Goldberg TL
J Gen Virol; 2013 Dec; 94(Pt 12):2670-2678. PubMed ID: 24077364
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of GB virus C/hepatitis G virus genotype 3 among autochthonous Venezuelan populations.
Loureiro CL; Alonso R; Pacheco BA; Uzcátegui MG; Villegas L; León G; De Saéz A; Liprandi F; López JL; Pujol FH
J Med Virol; 2002 Nov; 68(3):357-62. PubMed ID: 12226822
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infections in the Democratic Republic of Congo exhibit a cohort effect.
Iles JC; Abby Harrison GL; Lyons S; Djoko CF; Tamoufe U; Lebreton M; Schneider BS; Fair JN; Tshala FM; Kayembe PK; Muyembe JJ; Edidi-Basepeo S; Wolfe ND; Klenerman P; Simmonds P; Pybus OG
Infect Genet Evol; 2013 Oct; 19():386-94. PubMed ID: 23419346
[TBL] [Abstract][Full Text] [Related]
34. Impact of Blood Transfusion on the Prevalence of HHpgV-1, HPgV-1, and B19V Among Iranian HCV-infected Patients With Hemophilia.
Agi E; Hojjatipour S; Namvar A; Bolhassani A
J Pediatr Hematol Oncol; 2020 May; 42(4):e213-e218. PubMed ID: 31972722
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors of human pegivirus type 1 infection in hematopoietic stem cell transplantation patients.
Li Z; Li Y; Liang Y; Hu L; Chen S
Int J Infect Dis; 2019 Aug; 85():111-113. PubMed ID: 31170546
[TBL] [Abstract][Full Text] [Related]
36. RNA-Dependent RNA Polymerase of the Second Human Pegivirus Exhibits a High-Fidelity Feature.
Chen S; Wu J; Yang X; Sun Q; Liu S; Rashid F; Dzakah EE; Wang H; Wang J; Gong P; Tang S
Microbiol Spectr; 2022 Oct; 10(5):e0272922. PubMed ID: 35980196
[TBL] [Abstract][Full Text] [Related]
37. High prevalence and autochtonous transmission of human pegivirus (HPgV-1) in blood donors in the extreme southern of Brazil.
Da Mota LD; Finger-Jardim F; Silva CM; Germano FN; Nader MM; Gonçalves CV; Da Hora VP; Silveira J; Basso RP; Soares MA; Martínez AMB
J Med Virol; 2019 Jan; 91(1):31-37. PubMed ID: 30133818
[TBL] [Abstract][Full Text] [Related]
38. The Second Human Pegivirus, a Non-Pathogenic RNA Virus with Low Prevalence and Minimal Genetic Diversity.
Chen S; Wang H; Dzakah EE; Rashid F; Wang J; Tang S
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146649
[No Abstract] [Full Text] [Related]
39. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
40. High HPgV replication is associated with improved surrogate markers of HIV progression.
Horemheb-Rubio G; Ramos-Cervantes P; Arroyo-Figueroa H; Ávila-Ríos S; García-Morales C; Reyes-Terán G; Escobedo G; Estrada G; García-Iglesias T; Muñoz-Saucedo N; Kershenobich D; Ostrosky-Wegman P; Ruiz-Palacios GM
PLoS One; 2017; 12(9):e0184494. PubMed ID: 28910347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
